| __timestamp | ADMA Biologics, Inc. | Vertex Pharmaceuticals Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 4823869 | 305409000 |
| Thursday, January 1, 2015 | 6745968 | 377080000 |
| Friday, January 1, 2016 | 8494742 | 432829000 |
| Sunday, January 1, 2017 | 18092835 | 496079000 |
| Monday, January 1, 2018 | 22502922 | 557616000 |
| Tuesday, January 1, 2019 | 25910757 | 658498000 |
| Wednesday, January 1, 2020 | 35050817 | 770456000 |
| Friday, January 1, 2021 | 42896889 | 840100000 |
| Saturday, January 1, 2022 | 52458024 | 944700000 |
| Sunday, January 1, 2023 | 59020000 | 1136600000 |
| Monday, January 1, 2024 | 1464300000 |
Unlocking the unknown
In the competitive world of biotechnology, managing costs is crucial for success. This chart compares the Selling, General, and Administrative (SG&A) expenses of Vertex Pharmaceuticals Incorporated and ADMA Biologics, Inc. from 2014 to 2023. Over this period, Vertex Pharmaceuticals has consistently outpaced ADMA Biologics in SG&A spending, reflecting its larger scale and broader market reach. In 2023, Vertex's SG&A expenses were approximately 19 times higher than ADMA's, highlighting its significant investment in administrative and sales functions. ADMA Biologics, while smaller, has shown a steady increase in SG&A expenses, growing by over 1,100% from 2014 to 2023. This growth indicates ADMA's expanding operations and strategic investments in its business infrastructure. Understanding these trends provides valuable insights into each company's operational strategies and market positioning.
Selling, General, and Administrative Costs: Pfizer Inc. vs Vertex Pharmaceuticals Incorporated
Breaking Down SG&A Expenses: Vertex Pharmaceuticals Incorporated vs Zoetis Inc.
Vertex Pharmaceuticals Incorporated and Teva Pharmaceutical Industries Limited: SG&A Spending Patterns Compared
Who Optimizes SG&A Costs Better? Vertex Pharmaceuticals Incorporated or Exelixis, Inc.
Operational Costs Compared: SG&A Analysis of Vertex Pharmaceuticals Incorporated and Opthea Limited
Cost Management Insights: SG&A Expenses for Vertex Pharmaceuticals Incorporated and Ultragenyx Pharmaceutical Inc.
Vertex Pharmaceuticals Incorporated and Amneal Pharmaceuticals, Inc.: SG&A Spending Patterns Compared
Selling, General, and Administrative Costs: Vertex Pharmaceuticals Incorporated vs Viridian Therapeutics, Inc.
Intra-Cellular Therapies, Inc. vs ADMA Biologics, Inc.: SG&A Expense Trends
Halozyme Therapeutics, Inc. or ADMA Biologics, Inc.: Who Manages SG&A Costs Better?
Selling, General, and Administrative Costs: Axsome Therapeutics, Inc. vs ADMA Biologics, Inc.
Operational Costs Compared: SG&A Analysis of ADMA Biologics, Inc. and Mesoblast Limited